Morgan Stanley
OKYO

Morgan Stanley’s OKYO Pharma OKYO Stock Holding History

Morgan Stanley’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16 Hold
10
– – ﹤0.01% 8187
2025
Q4 		$21 Buy
+10
New +$22 ﹤0.01% 8078
2024
Q1 		– Sell
-27,692
Closed -$49K – 7931
2023
Q4 		$49K Buy
27,692
+13,846
+100% +$24.3K ﹤0.01% 6392
2023
Q3 		$25.6K Buy
+13,846
New +$23.3K ﹤0.01% 6411

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM

Morgan Stanley's OKYO Position: Q1 2026 in Review

Morgan Stanley held its OKYO Pharma (OKYO) position steady in Q1 2026 at 10 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #8187.

Morgan Stanley first reported a position in OKYO in Q3 2023 and has held it in 4 quarters since. The position peaked at $49K in Q4 2023. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • Morgan Stanley held 10 shares of OKYO Pharma worth $16 as of Q1 2026.
  • Morgan Stanley left its OKYO Pharma share count unchanged in Q1 2026.
  • OKYO Pharma made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #8187 holding.
  • Morgan Stanley first reported a position in OKYO Pharma in Q3 2023 and has held it in 4 quarters since.
  • Morgan Stanley's OKYO Pharma position peaked at $49K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.